This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Babcock International | Berenberg ups TP to 1350p from 1180p, Buy |
| Brammer | Investec ups TP to 470p from 450p, Buy |
| Capital Drilling | Liberum cuts TP to 30p from 60p, Buy |
| Chesnara | Panmure ups TP to 315p from 246p, Buy |
| Dixons Retail | JP Morgan ups TP to 33p from 28.4p, neutral |
| easyJet | Morgan Stanley ups TP to 1420p from 1380p, overweight |
| Hikma Pharmaceuticals | Jefferies ups TP to 1100p from 1040p, Buy |
| Hilton Food Group | Panmure ups TP to 415p from 380p, Buy |
| Invensys | SocGen ups TP to 445p from 415p, Buy |
| Kentz | HSBC cuts TP to 600P from 640P, overweight |
| Morrison | UBS ups TP to 270p from 250p, neutral |
| Pearson | Morgan Stanley ups TP to 1215p from 1140p, underweight |
| Pendragon | Panmure downgrades to Hold from sell, ups TP to 23p from 19p |
| Petrofac | SocGen ups to Buy from Hold |
| Petrofac | Liberum ups to Buy from Hold |
| Petrofac | HSBC cuts TP to 1275p from 1300p, underweight |
| Petrofac | UBS cuts TP to 1850p from 1875p, Buy |
| Synthomer | JP Morgan cuts TP to 220p from 230p, neutral |
| Talktalk Telecom | Morgan Stanley ups TP to 260p from 240p, Equalweight |
| Tate & Lyle | Jefferies ups TP to 980p from 900p, Buy |
| Thomas Cook | Morgan Stanley ups TP to 190p from 150p, overweight |
| Travis Perkins | UBS ups TP to 1500p from 1450p, neutral |
| Vectura | Berenberg ups TP to 180p from 145p, Buy |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research